Quidel announced Thursday that preliminary estimates for its third quarter revenues are expected to rise between 6 and 7 percent year over year on COVID-19 assay sales.

PerkinElmer said on Thursday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's assay to detect SARS-CoV-2 and the flu.

On Sep. 29, 2021, ET Healthcare announced that it was granted the ST2 patent of Critical Care Diagnostics, Inc. (CCD). So far, 7 Chinese companies have been legally authorized to manufacture and / or sell ST2 reagent products

Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a combined home collection kit for molecular testing for COVID-19 and influenza A/B.

Point-of-care testing firm EKF Diagnostics said on Wednesday that it has agreed to acquire Advanced Diagnostics Laboratory (ADL Health) for $10 million in shares and additional performance-based payments of up to $60 million over the next three years.

Genedrive announced on Wednesday that it has received CE marking for the next generation of its Genedrive System gene amplification platform.

On September 28, 2021, the " Fifteenth China Listed Company Value Evaluation " list sponsored by Securities Times and co-organized by Caitong Securities was announced. There are a number of in vitro diagnosis companies were listed.

Scienion said on Tuesday that it has entered into a strategic collaboration with diagnostic biotechnology company Pictor to commercialize a high throughput SARS-CoV-2 antibody testing system.

ANP Technologies announced on Monday that its SARS-CoV-2 rapid antigen test has received Emergency Use Authorization from the US Food and Drug Administration.

Sensor developer TE Connectivity announced on Sunday that it has acquired three companies to further expand its business into the in vitro diagnostic arena.

Novacyt on Monday reported a nearly 15 percent year-over-year decrease in revenues for the first half of 2021 as the French diagnostics firm held off on including revenues generated under a disputed SARS-CoV-2 test supply contract with the UK Department of Health and Social Care.

Beckman Coulter Life Sciences said on Monday that it has entered into an agreement with Invitae to develop applications for Beckman's new next-generation sequencing library preparation system.

On September 23, FDA sent a letter to all manufacturers that received EUA authorization for COVID-19 tests, urgently notifies all these manufacturers of three new requirements for their EUA-authorized tests.

GE (NYSE:GE) has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

On September 26, Hangzhou Matridx Biotechnology Co., Ltd. (hereinafter referred to as Matridx) announced that it had completed a strategic investment of hundreds of millions of yuan.

Lucid Diagnostics on Thursday announced a proposed initial public offering of its common stock.

Zymo Research announced on Thursday that its EZ DNA Methylation-Lightning Kit has received CE marking.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (“Mindray”) (300760.SZ), a leading global provider of medical devices and solutions, has completed its previously announced acquisition of HyTest Invest Oy and its subsidiaries (“HyTest”), a global leading provider of antibodies and antigens.

The agency is requiring test developers to monitor emerging mutations and their potential impact on the performance of authorized SARS-CoV-2 tests.

Investigators have determined that high-risk HPV DNA can be detected in saliva in most patients with HPV-driven oropharyngeal cancers at the time of diagnosis.